LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), has been ranked 15th on The Patent Board’s list of the top 67 biotechnology companies as determined by an assessment of the overall quality of each company’s patent portfolio. The Biotechnology Patent Scorecard is published quarterly in The Wall Street Journal and links a company’s patents to its core science and overall quality. The Patent Scorecard provides deeper insights into patent portfolios as measurable financial assets and drivers of market value.
